Introduction
Balancing robust privacy protections in Datavant's Connect product with the demand for more granular patient data from healthcare researchers presents a critical trade-off. This scenario involves navigating the delicate balance between data utility and patient privacy in the healthcare analytics space. I'll address this challenge by analyzing the product ecosystem, identifying key metrics, designing experiments, and providing a strategic recommendation.
I'd like to outline my approach to ensure we're aligned on the key areas I'll be covering in my analysis.
Step 1
Clarifying Questions (3 minutes)
Why it matters: Helps define the boundaries of what's legally possible Expected answer: HIPAA, GDPR, and state-specific regulations Impact on approach: Would influence the level of data granularity we can consider
Why it matters: Helps understand the financial implications of potential changes Expected answer: Tiered pricing based on data detail level Impact on approach: Would inform potential new product offerings or pricing adjustments
Why it matters: Helps prioritize which data elements are most critical Expected answer: Clinical trial recruitment, outcomes research, and drug safety studies Impact on approach: Would guide decisions on which data elements to prioritize for granularity
Why it matters: Determines the extent to which we can increase granularity while maintaining privacy Expected answer: Advanced techniques like differential privacy are in place, but with room for improvement Impact on approach: Would influence the potential solutions we can consider
Why it matters: Helps determine the urgency of implementing changes Expected answer: New privacy legislation expected in the next 12-18 months Impact on approach: Would affect the timeline for rolling out any changes
Practice similar questions
Subscribe to access the full answer